Michael A Metzger

Chief Executive Officer

Michael A Metzger (Chief Executive Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Syndax Pharmaceuticals, Inc. (SNDX). The largest single filing was $785K of SNDX (32,375 sh × $24.24, as filed), executed Jul 8.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.4M

shares × price, as filed

Last traded

Jul 8

Filed Jul 9

Median ADV $36.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

SNDX

Syndax Pharmaceuticals, Inc. SNDX · 0 buys · 7 sells 7 filings

Recent filings

SNDXSALE Syndax Pharmaceuticals, Inc. View filing → $785K
32,375 sh × $24.24
Exec Jul 8
Filed Jul 9 · 4:54 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. View filing → $130K
6,847 sh × $18.99
Exec Jun 1
Filed Jun 2 · 5:30 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. View filing → $361K
17,159 sh × $21.03
Exec Feb 9
Filed Feb 10 · 5:30 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. View filing → $153K
7,412 sh × $20.62
Exec Feb 6
Filed Feb 6 · 5:30 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. View filing → $2.6M
157,307 sh × $16.41
Exec Sep 8 2025
Filed Sep 8 2025 · 5:30 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. View filing → $118K
7,814 sh × $15.05
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. View filing → $206K
13,288 sh × $15.50
Exec Feb 10 2025
Filed Feb 12 2025 · 5:30 PM ET